Home
Products
API
FDF
Intermediate
CRO
About Us
Company Profile
Service
Resources
R&D
Research Institute
Solution
Quality System
News
Company News
Industry News
Contact Us
English
English
العربية
Français
Pусский
Español
Português
Email
Follow
Search
close
Choose Your Site
Global
Social Media
Home
Products
API
FDF
Intermediate
CRO
About Us
Company Profile
Service
Resources
R&D
Research Institute
Solution
Quality System
News
Company News
Industry News
Contact Us
Company News
You are here:
Home
»
News
»
Company News
Home
Contact Us
Latest News & Updates of Loncom Pharma
2026
DATE
07
- 29
Loncom Pharma’s Ertugliflozin Tablets Approved in China
Loncom Pharma develops Ertugliflozin Tablets, showcasing integrated API, formulation, manufacturing, and generic drug expertise.
Read More
2026
DATE
07
- 24
Loncom Pharma Strengthens GMP Compliance Culture Through the 10th GMP Knowledge Competition
Loncom Pharma strengthens GMP excellence through its 10th knowledge competition, enhancing quality culture and pharmaceutical manufacturing standards.
Read More
2026
DATE
07
- 21
Bestcomm Hosts 2026 New Employee Bootcamp, Empowering Graduates' Transition to the Workplace
Bestcomm held a three‑day 2026 new employee bootcamp in Jinan, integrating classroom learning, team‑building, and workshops.
Read More
2026
DATE
07
- 10
Bestcomm Ranked in Top 50 Pharmaceutical R&D Companies In China
Bestcomm won "Independent Innovation Enterprise" and "Top 50 R&D Company" at the 2025–2026 Industry Conference.
Read More
1
2
3
4
...
8
»
Total 8 pages Go to Page
Go
info@loncompharm.com
Tel: +86-531-87626506
Tel: +86-531-88114068
Tel: +86-531-88114952
Tel: +86-531-88285356
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong, China
QUICK LINKS
Home
Products
About Us
R&D
Quality System
News
Contact Us
PRODUCT CATEGORY
API
Finished Preparation
Intermediate
Copyright ©
2023
Shandong Loncom Pharmaceutical Co., Ltd. All Rights Reserved.
Sitemap
|
Privacy Policy
Supported by
leadong.com
Contact Us
Submit